SIREN : 792405227
CHARLENE OPTIQUE is a French company founded 13 years ago, specialized in the sector Commerces de détail d'optique. Based in MARSEILLE (13013), this company of category PME shows in 2021 a revenue of 373 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 372 798 € | 330 482 € | 297 599 € | 300 290 € | 292 575 € | 272 257 € |
| Net income | 19 802 € | 38 977 € | 38 210 € | 34 690 € | 18 150 € | 5 669 € |
| EBITDA | 37 740 € | 44 581 € | -11 384 € | 40 120 € | 42 645 € | 22 160 € |
| Net margin | 5.3% | 11.8% | 12.8% | 11.6% | 6.2% | 2.1% |
In 2021, CHARLENE OPTIQUE achieves revenue of 373 k€. Over the period 2016-2021, the company shows strong growth with a CAGR (compound annual growth rate) of +6.5%. Vs 2020, growth of +13% (330 k€ -> 373 k€). After deducting consumption (135 k€), gross margin stands at 238 k€, i.e. a rate of 64%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 38 k€, representing 10.1% of revenue. Warning negative scissor effect: despite revenue change (+13%), EBITDA varies by -15%, reducing margin by 3.4 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 20 k€, i.e. 5.3% of revenue. This profit can be retained or distributed to shareholders.
372 798 €
237 809 €
37 740 €
23 315 €
19 802 €
10.1%
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 9.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
22.583%
65.314%
9.12%
1.516
33.3%
In 2021, the debt ratio of CHARLENE OPTIQUE (22.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2021, the financial autonomy of CHARLENE OPTIQUE (65.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2021, the repayment capacity of CHARLENE OPTIQUE (1.52) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 341.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.8x. Financial charges are adequately covered by operations.
341.607
2.817
In 2021, the liquidity ratio of CHARLENE OPTIQUE (341.61) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2021, the interest coverage of CHARLENE OPTIQUE (2.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 4 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 54 days. Excellent situation: suppliers finance 50 days of the operating cycle (retail model). Inventory turnover is 96 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 80 days of revenue, i.e. 82 k€ to permanently finance.
82 332 €
4 j
54 j
96 j
80 j
Based on 105 transactions of similar company sales in 2021, the value of CHARLENE OPTIQUE is estimated at 131 415 € (range 78 967€ - 282 847€). With an EBITDA of 37 740€, the sector multiple of 3.4x is applied. The price/revenue ratio is 0.50x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 105 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CHARLENE OPTIQUE with other companies in the same sector:
Voir toutes les statistiques du secteur Commerces de détail d'optique
The revenue of CHARLENE OPTIQUE in 2021 is 373 k€.
Yes, CHARLENE OPTIQUE generated a net profit of 20 k€ in 2021.
The headquarters of CHARLENE OPTIQUE is located in MARSEILLE (13013), in the department Bouches-du-Rhone.
The tax return of CHARLENE OPTIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CHARLENE OPTIQUE operates in the sector Commerces de détail d'optique (NAF code 47.78A). See the 'Sector positioning' section above to compare the company with its competitors.